| PACKAGING TYPE: | 10x10 Alu-alu ( 10 Strip In 1 Box ) |
| COMPOSITION: | Gliclazide 30mg +metfomin Hydrochloride 500mg Tablet |
| FORMULATION: | Tablet |
| Description: | GLYZIMAC OD 30 Tablet is a combination antidiabetic medication containing: Gliclazide 30mg – a sulfonylurea that stimulates insulin secretion from pancreatic beta cells. Metformin Hydrochloride 500mg – a biguanide that reduces hepatic glucose production and improves insulin sensitivity. This dual-action combination is used for the management of Type 2 Diabetes Mellitus, helping to achieve better glycemic control when diet and exercise alone are insufficient. The formulation supports fast and sustained blood sugar control, reducing the risk of long-term diabetic complications. |
| Side Effects: | Common side effects: Nausea or diarrhea Abdominal discomfort Headache Hypoglycemia (low blood sugar) Rare but serious side effects: Lactic acidosis (rare, due to Metformin) Severe hypoglycemia Liver or kidney function abnormalities Allergic reactions (rash, swelling, difficulty breathing) |
| How to Use: | Take GLYZIMAC OD 30 Tablet orally, usually once daily with meals or as prescribed. Swallow the tablet whole with water. Do not skip meals to avoid hypoglycemia. Maintain a healthy diet and regular exercise routine. Monitor blood glucose levels regularly. |
| Precaution: | Monitor for signs of hypoglycemia (sweating, dizziness, confusion). Use cautiously in patients with kidney or liver impairment. Avoid excessive alcohol consumption (risk of lactic acidosis). Inform your doctor about other medications to avoid interactions. Not recommended during pregnancy or breastfeeding without medical advice. |
| Product Benefits: | Provides dual-action blood sugar control. Helps reduce both fasting and postprandial glucose levels. Improves insulin secretion and sensitivity. Reduces risk of diabetes-related complications. Suitable for once-daily dosing (OD) for better compliance. |
Frequently Asked Questions
It is used to manage Type 2 Diabetes Mellitus by controlling blood sugar levels.
OD stands for once daily dosing, making it convenient for patients.
Yes, due to Gliclazide, it may cause hypoglycemia, especially if meals are skipped.




















